The Value of Mitotic Count and Ki67 Proliferation Index in Congenital Mesoblastic Nephroma

References

• Bolande RP, Brough AJ, Izant RJ Jr. Congenital mesoblasticnephroma of infancy. A report of eight cases and the relationship to Wilms' tumor. Pediatrics. 1967;40(2):272–278.
   PubMed Web of Science ®Google Scholar
• England RJ, Haider N, Vujanic GM, Kelsey A, Stiller CA, Pritchard-Jones K, Powis M. Mesoblasticnephroma: a report of the United Kingdom children's cancer and Leukaemia group (CCLG). Pediatr Blood Cancer. 2011;56(5):744–748.
   PubMed Web of Science ®Google Scholar
• Kim CH, Kim YH, Cho MK, Kim KM, Ha JA, Joo EH, Kim SM, Song TB. A case of fetal congenital mesoblasticnephroma with oligohydramnios. J Korean Med Sci. 2007;22(2):357–361.
   PubMed Web of Science ®Google Scholar
• Anunobi CC, Badmos KB, Onyekwelu VI, Ikeri NZ Congenital mesoblasticnephroma in a premature neonate: a case report and review of literature. Niger J Clin Pract. 2014;17(2):255–259.
   PubMed Web of Science ®Google Scholar
• Blank E, Neerhout RC, Burry KA. Congenital mesoblasticnephroma and polyhydramnios. JAMA. 1978;240(14):1504–1505.
   PubMed Web of Science ®Google Scholar
• Saurabh K, Yadav R, Sharma S, Gupta R. Congenital mesoblasticnephroma: A rare cause of recurrent hematuria beyond infancy. Indian J Nephrol. 2013;23(4):322–323.
   PubMedGoogle Scholar
• Hu JM, Wu TT, Chan SW, Cheng SL, Chen SM, Sheu JN. Congenital mesoblasticnephroma presenting with massive hematuria and hemorrhagic shock: report of one case. Acta Paediatr Taiwan. 2006;47(3):135–138.
   PubMedGoogle Scholar
• Wang ZP, Li K, Dong KR, Xiao XM, Zheng S. Congenital mesoblasticnephroma: clinical analysis of eight cases and a review of the literature. Oncol Lett. 2014;8(5):2007–2011.
   PubMed Web of Science ®Google Scholar
• Glick RD, Hicks MJ, Nuchtern JG, Wesson DE, Olutoye OO, Cass DL. Renal tumors in infants less than 6 months of age. J Pediatr Surg. 2004;39(4):522–525.
   PubMed Web of Science ®Google Scholar
• MacLennan GT, Cheng L. Neoplasms of the kidney. In: Urologic Surgical Pathology, 3rd ed.. Bostwick DG, Cheng L, eds. Philadelphia: Elsevier Saunders; 2014. pp. 134–135.
   Google Scholar
• Knezevich SR, Garnett MJ, Pysher TJ, Beckwith JB, Grundy PE, Sorensen PH. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblasticnephroma and congenital fibrosarcoma. Cancer Res. 1998;58(22):5046–5048.
   PubMed Web of Science ®Google Scholar
• Argani P, Fritsch M, Kadkol SS, Schuster A, Beckwith JB, Perlman EJ. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblasticnephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Mod Pathol. 2000;13(1):29–36.
   PubMed Web of Science ®Google Scholar
• Anderson J, Gibson S, Sebire NJ. Expression of ETV6-NTRK in classical, cellular and mixed subtypes of congenital mesoblasticnephroma. Histopathology. 2006;48(6):748–753.
   PubMed Web of Science ®Google Scholar
• Heidelberger KP, Ritchey ML, Dauser RC, McKeever PE, Beckwith JB. Congenital mesoblasticnephroma metastatic to the brain. Cancer. 1993;72(8):2499–2502.
   PubMed Web of Science ®Google Scholar
• Ko SM, Kim MJ, Im YJ, Park KI, Lee MJ. Cellular mesoblasticnephroma with liver metastasis in a neonate: prenatal and postnatal diffusion-weighted MR imaging. Korean J Radiol. 2013;14(2):361–365.
   PubMed Web of Science ®Google Scholar
• Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182(3):311–322.
   PubMed Web of Science ®Google Scholar
• Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B; all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395–401.
   PubMed Web of Science ®Google Scholar
• Weikel W, Brumm C, Wilkens C, Beck T, Knapstein PG. Growth fractions (Ki-67) in primary breast cancers, with particular reference to node-negative tumors. Cancer Detect Prev. 1995;19(5):446–450.
   PubMedGoogle Scholar
• Ueda T, Aozasa K, Tsujimoto M, Ohsawa M, Uchida A, Aoki Y, Ono K, Matsumoto K. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer. 1989;63(8):1607–1611.
   PubMed Web of Science ®Google Scholar
• Pettinato G, Manivel JC, Wick MR, Dehner LP. Classical and cellular (atypical) congenital mesoblasticnephroma: a clinicopathologic, ultrastructural, immunohistochemical, and flow cytometric study. Hum Pathol. 1989;20(7):682–690.
   PubMed Web of Science ®Google Scholar
• Whittle S, Gosain A, Brown PYS, Debelenko L, Raimondi S, Wilimas JA, Jenkins JJ, Davidoff AM. Regression of a congenital mesoblastic nephroma. Pediatr Blood Cancer. 2010;55:364–368.
   PubMed Web of Science ®Google Scholar
• Sydney Correia L, Diego Marques F, Garcia Dias B, Oliveira WR, de Oliveira SM, Uchoa Rangel MR. Mixed subtype of congenital mesoblasticnephroma with poor evolution: a case report and literature review. Radiol Bras. 2015;48(6):396–398.
   PubMedGoogle Scholar
• Bayindir P, Guillerman RP, Hicks MJ, Chintagumpala MM. Cellular mesoblasticnephroma (infantile renal fibrosarcoma): institutional review of the clinical, diagnostic imaging, and pathologic features of a distinctive neoplasm of infancy. Pediatr Radiol. 2009;39(10):1066–1074.
   PubMed Web of Science ®Google Scholar
• van den Heuvel-Eibrink MM, Grundy P, Graf N, Pritchard-Jones K, Bergeron C, Patte C, van Tinteren H, Rey A, Langford C, Anderson JR, de Kraker J. Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: a collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups. Pediatr Blood Cancer. 2008;50(6):1130–1134.
   PubMed Web of Science ®Google Scholar
• Isaacs H Jr. Fetal and neonatal renal tumors. J Pediatr Surg. 2008;43(9):1587–1595.
   PubMed Web of Science ®Google Scholar
• Marsden HB, Newton WA Jr. New look at mesoblasticnephroma. J ClinPathol. 1986;39(5):508–513.
   Google Scholar
• Gormley TS, Skoog SJ, Jones RV, Maybee D. Cellular congenital mesoblasticnephroma: what are the options. J Urol. 1989;142(2 Pt 2):479–483; discussion 489.
   PubMed Web of Science ®Google Scholar
• Loeb DM, Hill DA, Dome JS. Complete response of recurrent cellular congenital mesoblasticnephroma to chemotherapy. J Pediatr Hematol Oncol. 2002;24(6):478–481.
   PubMed Web of Science ®Google Scholar
• Furtwaengler R, Reinhard H, Leuschner I, Schenk JP, Goebel U, Claviez A, Kulozik A, Zoubek A, von Schweinitz D, Graf N. Gesellschaft fur PädiatrischeOnkologie und Hämatologie (GPOH) Nephroblastoma Study Group. Mesoblasticnephroma–a report from the Gesellschaft fur PädiatrischeOnkologie und Hämatologie (GPOH). Cancer. 2006;106(10):2275–2283.
   PubMed Web of Science ®Google Scholar
• Beckwith JB, Weeks DA. Congenital mesoblasticnephroma. When should we worry? Arch Pathol Lab Med. 1986;110(2):98–99.
   PubMed Web of Science ®Google Scholar